A 6-chloropurine-resistant strain of Escherichia coli has been used to develop a microbiological assay for the estimation of 5-azacytidine distribution in mouse tissues.
5-Azacyidine (NSC 102816), a new antitumor agent, has been reported to strongly inhibit lymphoid leukemia in mice (5, 6) , and clinical studies are now in progress. The successful development of a potentially useful chemotherapeutic agent is dependent in part on the ability to measure tissue distribution and concentration of select an appropriate microorganism for the assay of 5-azacytidine. From more than 100 species of bacteria tested for sensitivity to this compound, a strain derived from E. coli ATCC 9637 as resistant to 6-chloropurine (designated E. coli/6-chloropurine) was selected as the assay organism. The culture is maintained on agar slants of a simple The suspension was diluted 1:200 in saline, and 10 ml of this suspension was added to 1 liter of cooled (50 to 55 C) glucose-salts medium. A 5-ml amount of the inoculated agar was added to the previously described plates containing 8 ml of congealed sterile agar. E. coli/6-CPU is a stable mutant and the addition of 6-CPU to the assay plates is not required. A stock solution of 5-azacytidine was prepared in sterile saline and was appropriately diluted so that 0.08 ml of the various dilutions was added to filter-paper discs (1.27 cm in diameter). The following concentrations were obtained (micrograms of 5-azacytidine/disc): 0.01, 0.02, 0.04, 0.06, 0.08, 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, and 3.0. An additional 5-azacytidine stock solution was prepared in which the drug was dissolved in mouse blood and diluted with saline. Filter-paper discs (1.27 cm in diameter, no. 740-E, Schleicher and Schuell Co., Keene, N.H.) were impregnated with 0.08 ml of the respective solutions containing graded concentrations of the drug. These discs were placed on the surface of each seeded agar plate and pressed down securely with flamed forceps. All plates and drug concentrations per disc were prepared in triplicate. Each individual plate contained a maximum of three discs. Two discs contained, individually, either experimental samples or standard curve solutions of different concentrations. A third control disc, containing an empirically selected concentration (3.0 4g of 5-azacytidine/disc) was added to each plate, which allowed for correction of plate-to-plate variation in zone sizes. All plates were incubated at 37 C for 18 to 22 hr simultaneously with plates which contained discs impregnated with blood from animals which received 5-azacytidine. The resulting zones of inhibition on the triplicate standard plates were measured and corrected as follows. If the mean diameter of all the control disc zones is greater than that of an individual control disc zone, the difference is added to all of the zones on that plate. Conversely, if the average diameter of the control disc zones is less than that of an individual control disc, the difference is subtracted from all the zones on that plate. The mean diameter of these corrected zones is determined for each drug concentration and entered on semilogarithmic paper-the diameter of zones on the ordinate and concentrations of drug/disc on the abscissa. A straight line of best fit is drawn through the points thus obtained. This line constitutes a standard curve (see Fig. 1 
